BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31067847)

  • 1. [A Case of Prostate Cancer with High Levels of Prostate-Specific Antigen Undetected by Prostate Biopsy].
    Shimizu K; Nakano S; Okada Y; Nagahama K; Okubo K; Yasuhara Y
    Hinyokika Kiyo; 2019 Mar; 65(3):75-80. PubMed ID: 31067847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of prostate cancer diagnosed by lymphadenectomy].
    Fukumoto R; Soda T; Uehara M; Hayashi T; Oka D; Fujimoto N; Koide T
    Hinyokika Kiyo; 2012 Oct; 58(10):557-60. PubMed ID: 23235279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy.
    Sciarra A; Panebianco V; Cattarino S; Busetto GM; De Berardinis E; Ciccariello M; Gentile V; Salciccia S
    BJU Int; 2012 Dec; 110(11):1661-5. PubMed ID: 22564540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer with supraclavicular lymphadenopathy and bulky abdominal tumor.
    Kosugi S; Mizumachi S; Kitajima A; Igarashi T; Hamada T; Kaya H; Kurihara K; Ogasawara K; Sakata H; Yamamoto M; Nagamine M; Yamazaki H
    Intern Med; 2007; 46(14):1135-8. PubMed ID: 17634715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of prostate cancer diagnosed pathologically by bone metastatic site biopsy].
    Nakata S; Nakano K; Takahashi H; Shimizu K; Higashi H; Ohki K
    Nihon Hinyokika Gakkai Zasshi; 2005 May; 96(4):507-10. PubMed ID: 15948412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detecting lymph nodes metastasis in prostate cancer through extended vs. standard laparoscopic pelvic lymphadenectomy.
    Arenas LF; Füllhase C; Boemans P; Fichtner J
    Aktuelle Urol; 2010 Jan; 41 Suppl 1():S10-4. PubMed ID: 20094944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the local control in lymph-node staged localized prostate cancer treated by external beam radiotherapy, assessed by digital rectal examination, serum prostate-specific antigen and biopsy.
    Borghede G; Aldenborg F; Wurzinger E; Johansson KA; Hedelin H
    Br J Urol; 1997 Aug; 80(2):247-55. PubMed ID: 9284197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prostate cancer diagnosed through the biopsy of the bone metastatic lesion; a case report].
    Ueda Y; Higuchii Y; Hashimoto T; Mitsui Y; Maruyamai T; Kondou N; Nojima M; Yamamoto S; Shincho M; Hirota S; Shima H
    Hinyokika Kiyo; 2007 May; 53(5):327-30. PubMed ID: 17561720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Delay in High-Grade Metastatic Prostate Cancer Progression by Dutasteride : A Case Report].
    Yamada Y; Fujiwara H; Somiya S; Fujikawa S; Kamiyama Y; Tamaki M; Kanaoka T
    Hinyokika Kiyo; 2018 Apr; 64(4):187-192. PubMed ID: 29772622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic significance of prostate-specific antigen in defining indications for initial prostate biopsy].
    Popov SV; Guseinov RG; Skryabin ON; Orlov IN; Martov AG
    Urologiia; 2018 Jul; (3):92-97. PubMed ID: 30035426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High diagnostic ability of multiparametric magnetic resonance imaging to detect anterior prostate cancer missed by transrectal 12-core biopsy.
    Komai Y; Numao N; Yoshida S; Matsuoka Y; Nakanishi Y; Ishii C; Koga F; Saito K; Masuda H; Fujii Y; Kawakami S; Kihara K
    J Urol; 2013 Sep; 190(3):867-73. PubMed ID: 23542406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A Case of Prostate Cancer Diagnosed by the Bone Biopsy of the Right Iliac Metastatic Lesion].
    Konishi M; Okamoto S; Yamamoto T; Kanaki T; Oshima J; Kinjo T; Nakata W; Ohashi H; Inoue H
    Hinyokika Kiyo; 2023 Jul; 69(7):193-197. PubMed ID: 37558641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of prostate imaging reporting and data system (PI-RADS) score and prostate-specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naïve patients.
    Washino S; Okochi T; Saito K; Konishi T; Hirai M; Kobayashi Y; Miyagawa T
    BJU Int; 2017 Feb; 119(2):225-233. PubMed ID: 26935594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role of multifactorial evaluation of prostatic 3T MRI in patients with elevated prostatic-specific antigen levels: prospective comparison with ultrasound-guided transrectal biopsy.
    Ferda J; Kastner J; Hora M; Hes O; Fínek J; Topolčan O; Kreuzberg B
    Anticancer Res; 2013 Jun; 33(6):2791-5. PubMed ID: 23749943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.
    Heidenreich A; Varga Z; Von Knobloch R
    J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Magnetic Resonance Imaging in Prostate Cancer Screening: A Pilot Study Within the Göteborg Randomised Screening Trial.
    Grenabo Bergdahl A; Wilderäng U; Aus G; Carlsson S; Damber JE; Frånlund M; Geterud K; Khatami A; Socratous A; Stranne J; Hellström M; Hugosson J
    Eur Urol; 2016 Oct; 70(4):566-573. PubMed ID: 26724840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
    Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
    J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An assessment of the usefulness of serum prostate-specific antigen level and cancer volume in biopsy specimens to predict the extent of prostate cancer.
    Gohji K; Nomi M; Kizaki T; Morisue K; Okamoto M; Takenaka A; Fujii A
    Br J Urol; 1997 Apr; 79(4):602-7. PubMed ID: 9126092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Endometrioid adenocarcinoma of the prostate: a case report].
    Tsutahara K; Fukuhara S; Mori N; Hara T; Yamaguchi S; Adachi S; Fujisue K
    Hinyokika Kiyo; 2004 Sep; 50(9):649-52. PubMed ID: 15518134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.